Middle Latency Somatosensory Evoked Potentials in Hemiparkinsonism

A. SOYSAL, F. ÖZER, B. ARPACI

Issue: 1999, Volume 5 - Issue 2
0 209

lron Deficiency and Restless Legs Syndrome; Three Cases

C. TOGAY IŞIKAY, A. BİNGÖL, N. MUTLUER

Issue: 1999, Volume 5 - Issue 2
0 294

Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 250

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 250

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 275

Subacute Myleo-Optic Neuropathy- Case Report

Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS

Issue: 1998, Volume 4 - Issue 3-4
0 216

Therapentic Advances In Multiple Sclerosis

Egemen İDİMAN

Issue: 1998, Volume 4 - Issue 1-2
0 224

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 226

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 256

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 210

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 260

Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN

Issue: 1995, Volume 1 - Issue 1
0 228

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 295

Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance

Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc

DOI: 10.55697/tnd.2024.110

Issue: 2024, Volume 30 - Issue 2
882 571

Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis

Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak

DOI: 10.55697/tnd.2024.8

Issue: 2024, Volume 30 - Issue 2
1618 799

Impulse control disorders related cognitive and behavioral features in Parkinson’s disease

Esra Erkoc Ataoglu, Yasemin Bozdağ, Ayse Bora Tokcaer

DOI: 10.55697/tnd.2024.109

Issue: 2024, Volume 30 - Issue 3
1015 596

Scale consistance in cognitive status awareness of patients with Parkinson’s disease

Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı

DOI: 10.55697/tnd.2024.139

Issue: 2024, Volume 30 - Issue 3
618 364

The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment

Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil

DOI: 10.55697/tnd.2025.216

Issue: 2025, Volume 31 - Issue 1
125 92

Relationship between subjective sleep quality and serum ghrelin levels in Parkinson’s disease

Alper Ayaslı, Yıldız Değirmenci, Davran Fat, Mehmet Ali Sungur

DOI: 10.55697/tnd.2025.137

Issue: 2025, Volume 31 - Issue 1
88 73